MX2014014839A - Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion. - Google Patents

Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion.

Info

Publication number
MX2014014839A
MX2014014839A MX2014014839A MX2014014839A MX2014014839A MX 2014014839 A MX2014014839 A MX 2014014839A MX 2014014839 A MX2014014839 A MX 2014014839A MX 2014014839 A MX2014014839 A MX 2014014839A MX 2014014839 A MX2014014839 A MX 2014014839A
Authority
MX
Mexico
Prior art keywords
neuroprotection
cannabidiol
hypothermia
synergistic therapies
therapies
Prior art date
Application number
MX2014014839A
Other languages
English (en)
Other versions
MX356052B (es
Inventor
Geoffrey Guy
José Martinez-Orgado
Original Assignee
Gw Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gw Pharma Ltd filed Critical Gw Pharma Ltd
Publication of MX2014014839A publication Critical patent/MX2014014839A/es
Publication of MX356052B publication Critical patent/MX356052B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
    • A61F2007/0056—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water for cooling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a la combinación del fitocannabinoide cannabidiol con hipotermia terapéutica para usarse en el tratamiento de neuroprotección o astroprotección.
MX2014014839A 2012-06-08 2013-06-10 Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion. MX356052B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1210142.4A GB2504263B (en) 2012-06-08 2012-06-08 Synergistic therapies for neuroprotection
PCT/GB2013/051519 WO2013182862A1 (en) 2012-06-08 2013-06-10 Synergistic therapies of cannabidiol with hypothermia for neuroprotection

Publications (2)

Publication Number Publication Date
MX2014014839A true MX2014014839A (es) 2015-02-12
MX356052B MX356052B (es) 2018-05-11

Family

ID=46605623

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014839A MX356052B (es) 2012-06-08 2013-06-10 Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion.

Country Status (18)

Country Link
US (1) US10220005B2 (es)
EP (1) EP2858633B1 (es)
JP (1) JP6284525B2 (es)
BR (1) BR112014030406A8 (es)
CA (1) CA2874968C (es)
CY (1) CY1118118T1 (es)
DK (1) DK2858633T3 (es)
ES (1) ES2583830T3 (es)
GB (1) GB2504263B (es)
HR (1) HRP20160905T1 (es)
HU (1) HUE028822T2 (es)
MX (1) MX356052B (es)
PL (1) PL2858633T3 (es)
PT (1) PT2858633T (es)
RS (1) RS55029B1 (es)
SI (1) SI2858633T1 (es)
SM (1) SMT201600265B (es)
WO (1) WO2013182862A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10525039B2 (en) 2015-12-16 2020-01-07 Neurophyxia B.V. 2-iminobiotin for use in the treatment of brain cell injury
WO2018000094A1 (en) 2016-06-29 2018-01-04 CannScience Innovations Inc. Decarboxylated cannabis resins, uses thereof and methods of making same
GB2597281A (en) 2020-07-20 2022-01-26 Gw Res Ltd Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2434312B (en) 2006-01-18 2011-06-29 Gw Pharma Ltd Cannabinoid-containing plant extracts as neuroprotective agents
WO2009071096A2 (en) * 2007-12-05 2009-06-11 Neurokey A/S Combination of medical and physical cooling treatment of ischemic effects

Also Published As

Publication number Publication date
BR112014030406A8 (pt) 2021-06-22
GB2504263A (en) 2014-01-29
RS55029B1 (sr) 2016-11-30
MX356052B (es) 2018-05-11
PT2858633T (pt) 2016-07-29
US20150148872A1 (en) 2015-05-28
GB201210142D0 (en) 2012-07-25
HRP20160905T1 (hr) 2016-09-23
CA2874968C (en) 2020-02-18
SMT201600265B (it) 2016-08-31
SI2858633T1 (sl) 2016-10-28
HUE028822T2 (en) 2017-01-30
US20150328171A2 (en) 2015-11-19
BR112014030406A2 (pt) 2017-06-27
US10220005B2 (en) 2019-03-05
EP2858633A1 (en) 2015-04-15
EP2858633B1 (en) 2016-07-13
DK2858633T3 (en) 2016-08-15
US20160243054A2 (en) 2016-08-25
CY1118118T1 (el) 2017-06-28
PL2858633T3 (pl) 2016-11-30
JP2015518875A (ja) 2015-07-06
JP6284525B2 (ja) 2018-02-28
GB2504263B (en) 2015-09-16
ES2583830T3 (es) 2016-09-22
WO2013182862A1 (en) 2013-12-12
CA2874968A1 (en) 2013-12-12

Similar Documents

Publication Publication Date Title
IL269041A (en) Tesmelteon for use in the treatment of asynchronous circadian rhythm of cortisol
IL269852B (en) Combined treatments and uses for the treatment of demyelination disorders
HRP20190046T1 (hr) Kombinirana terapija za liječenje raka
PH12016501139A1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
HK1222552A1 (zh) 索布替羅用於治療髓鞘形成疾病
HK1221408A1 (zh) 用於治療成膠質細胞瘤的組合療法
MX2015006234A (es) Uso de akkermansia para tratar trastornos metabolicos.
IL263661A (en) Combination therapy for the treatment of glioblastoma
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
IL242386B (en) Use of Aribolin and Lavetinib as a combination therapy for cancer treatment
EP2830633A4 (en) COMBINATION THERAPY FOR CANCER TREATMENT
EP3061452A4 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
PH12015500663A1 (en) Pharmaceutical combinations comprising dual angiopoietin-2/dll4 binders and anti-vegf-r agents
MX356052B (es) Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion.
MX2014012535A (es) Terapia de combinacion de anticuerpos anti-mif y quimioterapeuticos.
MX369774B (es) Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos.
IL233495A0 (en) Combination for cancer treatment
AU2012904010A0 (en) Combination therapy to reduce the risk of and to treat cancer
UA80747U (ru) Применение препарата октенисепт как средства для санации полостей суставов при лечении метаэпифизарного остеомиелита
UA67953U (ru) Установка для лечения вирусных гепатитов с использованием медицинского озона

Legal Events

Date Code Title Description
FG Grant or registration